DiscoveryProbe Bioactive Compound Library Plus in Ligand Scr
2026-07-18
The DiscoveryProbe™ Bioactive Compound Library Plus accelerates high-throughput pathway analysis and ligand discovery in bacterial sensor research. Its 5072 compound diversity, rigorous QC, and pre-dissolved 10 mM DMSO format streamline thermal shift and functional assays, bridging mechanistic insight with translational potential.
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-07-17
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit enables high-resolution separation of small proteins and peptides (1–10 kDa) that are not efficiently resolved by conventional Tris-glycine SDS-PAGE systems. It is intended for research workflows focused on low molecular weight protein and peptide analysis and should not be used for diagnostic, clinical, or medical applications.
nor-NOHA Acetate: Applied Arginase Inhibition in Cancer Mode
2026-07-17
nor-NOHA acetate from APExBIO enables precise, reversible arginase inhibition, driving reproducible results in cancer metabolism research. This guide details advanced workflows, troubleshooting strategies, and the latest insights linking arginine metabolism to immune escape mechanisms.
Dual Inhibition of BRD4 and RAC1 Disrupts Breast Cancer Epig
2026-07-16
This study uncovers a novel therapeutic strategy in breast cancer by co-targeting BET bromodomain BRD4 and RAC1, resulting in suppressed tumor growth and stemness via epigenetic circuit disruption. The findings highlight the mechanistic impact of disrupting the c-MYC-G9a-FTH1 axis and downregulating HDAC1, offering new directions for cancer epigenetics research.
Anti-RPS6 (7B10) Antibody: Mechanistic Precision in Ribosome
2026-07-16
Explore the advanced capabilities of the Anti-RPS6 antibody in ribosome biogenesis and cancer cell signaling research. This article delivers unique mechanistic insights and practical assay guidance, setting it apart from existing content.
Empowering Estrogen Research with PPT (Propyl Pyrazole Triol
2026-07-15
This article delivers scenario-driven solutions for estrogen receptor research, highlighting how 'PPT (Propyl Pyrazole Triol), a potent, selective ERα agonist' (SKU B6735) addresses common experimental challenges. Practical Q&A blocks, grounded in current literature and real laboratory contexts, guide researchers to reproducible, selective, and efficient ERα signaling studies using this APExBIO reagent.
Sulfachloropyridazine Alters Cecal Microbiota in Eimeria Inf
2026-07-15
The referenced study uses 16S rRNA sequencing and metabolomics to analyze how sulfachlorpyridazine, ethanamizuril, and their combination affect the cecal microbial and metabolite profiles in chickens infected with Eimeria tenella. This integrative approach reveals that sulfachlorpyridazine modulates harmful bacterial populations and provides new tools for monitoring therapeutic efficacy in avian infection models.
Gentamycin Sulfate: Applied Workflows for Resistance and Rib
2026-07-14
Gentamycin Sulfate stands out as a robust aminoglycoside antibiotic for dissecting bacterial protein synthesis and modeling antibiotic resistance mechanisms. This article delivers actionable protocols, troubleshooting strategies, and evidence-based insights tailored for advanced microbiology research.
Sulfaphenazole: Precision CYP2C9 Inhibitor in Vascular Resea
2026-07-14
Sulfaphenazole empowers researchers with selective CYP2C9 inhibition for drug metabolism, vascular function, and antibacterial investigations. Discover how to optimize workflows and overcome common experimental hurdles with this robust, low-toxicity tool compound.
Optimizing Cell Assays with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)
2026-07-13
Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) provides robust, dual-fluorescent solutions to common challenges in mRNA delivery and translation efficiency assays. This article presents real-world laboratory scenarios, data-driven recommendations, and protocol parameters for reliable gene regulation and cytotoxicity workflows.
Hydroxytyrosol Workflows: Elevating Antioxidant Research Pre
2026-07-13
Hydroxytyrosol (4-(2-hydroxyethyl)benzene-1,2-diol) empowers reproducible oxidative stress and inflammation studies with high solubility and purity. This guide details advanced experimental protocols, troubleshooting strategies, and translational insights for maximizing APExBIO’s Hydroxytyrosol in cardiovascular and renal disease models.
hiPSC-Derived Intestinal Organoids for Pharmacokinetic Studi
2026-07-12
This study establishes a streamlined protocol for deriving intestinal organoids from human pluripotent stem cells (hiPSCs), enabling more physiologically relevant in vitro pharmacokinetic modeling. The organoids exhibit mature enterocyte features, including key drug-metabolizing enzyme activities, addressing major limitations of traditional cell and animal models.
GW 6471 in Translational Lipidomics: Precision Tools for PPA
2026-07-10
Explore how GW 6471, a selective PPARα antagonist from APExBIO, is reshaping translational research into lipid metabolism and metabolic disease. This thought-leadership article integrates mechanistic insight, emerging toxicology data, and practical protocol guidance—bridging environmental science and preclinical disease modeling. Drawing on recent zebrafish PFHxS studies, it charts a strategic path for researchers seeking reproducibility, mechanistic depth, and clinical relevance in PPARα-targeted workflows.
Sphingolipid Synthesis Inhibition Reduces Ferroptosis via HI
2026-07-09
Liu et al. demonstrate that pharmacological inhibition of sphingolipid synthesis by myriocin protects neuronal cells from ferroptosis through activation and stabilization of HIF-1α, independent of glutathione restoration. These findings reveal a novel metabolic control point in ferroptosis regulation with implications for neuroprotection strategies in neurological disease models.
FAST Enables Surfactant-Free Nutraceutical Nanoparticles for
2026-07-09
Cai et al. introduce Facilitated Self-Assembling Technology (FAST) as a food-grade approach for generating stable, bioavailable nutraceutical nanoparticles without synthetic surfactants. Their work demonstrates scalable production, enhanced colloidal stability, and improved cell compatibility, supporting regulatory and consumer demands for safer oral supplement delivery.
466 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page